جستجوی استاد راهنمای دانشگاهی

Hang Lu is an Associate Professor in the Department of Communication and Media at the University of Michigan's College of Literature, Science, and the Arts. He specializes in science, health, environmental, and risk communication (ComSHER), with a focus on media psychology. His research explores audience responses to media messages about sensitive topics and strategies to enhance message effectiveness. Lu holds a Ph.D. in Communication from Cornell University (2018), along with advanced degrees from Cornell, Marquette University, and Central South University in China. He directs the Media and Risk (MaR) Lab and previously served as a postdoctoral fellow at the Annenberg Public Policy Center. His research spans four main areas: 1) emotion dynamics in media responses, 2) predictors of information behaviors, 3) media effects on stigmatization, and 4) AI applications in sensitive domains. He has published in journals like Journal of Communication , Risk Analysis , and Public Understanding of Science , earning multiple top paper awards. As Vice Chair of the Environmental Communication Division at the International Communication Association, Lu contributes to interdisciplinary dialogue. His work addresses critical societal issues such as climate change communication, vaccination hesitancy, and emerging technology ethics.

• Science Communication
• Health Communication
• Environmental Communication
• +۴ مورد دیگر

Scott Forth is an Associate Professor in the Department of Biological Sciences at Rensselaer Polytechnic Institute's School of Science. He specializes in biophysics, focusing on microtubule networks in cell division and neuronal development. Ph.D. in Physics from Cornell University (2009) B.S. in Physics and B.M. in Music Performance from Oberlin College (2002) Postdoctoral Fellow at Rockefeller University (2010-2016) His research combines optical trapping and fluorescence microscopy to study how forces are transmitted across biopolymer networks. Key areas include: Mechanics of mitotic microtubule networks PRC1-mediated force resistance in cell division Kinesin motor protein dynamics Single-molecule biophysical methods Neuronal cytoskeleton organization Recent work analyzes force generation in reconstituted microtubule bundles and mechanical roles of proteins like PRC1 and kinesin-5. Scientific Awards Ruth Kirschstein National Research Service Award (NIH postdoctoral F32) Rensselaer School of Science Outstanding Teacher Award Rensselaer School of Science Early Career Research Award Biophysical Society Early Career Award (Motility and Cytoskeleton Subgroup) Dr. Forth's lab studies how nanometer-scale proteins coordinate to create micron-scale cellular mechanics. Current projects focus on microtubule network organization during cell division and neuronal development.

• Biophysics
• Mechanics of Cell Division
• Neuronal Cytoskeleton
• +۳ مورد دیگر

Prof. Dr. Jochen Herms serves as Director at the LMU Center for Neuropathology and Prion Research , while maintaining a dual affiliation with the German Center for Neurodegenerative Diseases (DZNE) Munich as Head of Translational Brain Research. His work bridges clinical and experimental neuropathology, focusing on synaptic degeneration in neurodegenerative conditions. Ludwig-Maximilians-Universität München (LMU): Director, Experimental Neuropathology DZNE Munich: Translational Brain Research Research Themes: Primary: Biomedical Neuroscience Secondary: Cellular & Systems Neuroscience Tertiary: Behavioral & Cognitive Neuroscience Key investigations include: Physiological roles of neurodegenerative disease proteins (APP, presenilins, BACE, tau, α-synuclein) In vivo two-photon imaging of transgenic Alzheimer's models Neuronal calcium homeostasis in neurodegeneration High-throughput drug screening for AD/PD Active research collaborations leverage funding from: German Research Foundation (DFG) - Munich Cluster for Systems Neurology (EXC 2145 SyNergy) BMBF, BMWi, EU consortia Bavarian Research Foundation Wilhelm Sander Foundation

• Biomedical Neuroscience
• Cellular & Systems Neuroscience
• Behavioral & Cognitive Neuroscience
• +۵ مورد دیگر

Dr. Meng Deng is an Associate Professor in Agricultural & Biological Engineering at Purdue University, specializing in biomaterials, regenerative engineering, and drug delivery. He holds a B.E. from Tsinghua University and a Ph.D. from the University of Virginia, with postdoctoral training at the University of Connecticut Health Center and MIT. His research focuses on designing polymeric biomaterials for musculoskeletal tissue regeneration and controlled drug delivery, including nanoparticle-based therapies for obesity and metabolic disorders. He has received awards such as the Society for Biomaterials STAR Award and Young Scientist Award (2012 World Biomaterials Congress). His work integrates nanotechnology and bioengineering to develop inductive materials that modulate cell behavior. Current research interests include bioactive hydrogels, muscle regeneration, and browning of white adipose tissue. Dr. Deng advises postdoctoral fellows, graduate students, and undergraduates in his lab at Regenerative Matter, with publications available via Google Scholar. Affiliations: Purdue University Department of Agricultural & Biological Engineering Key Research Themes: Biomaterials, Drug Delivery, Nanotechnology His lab explores applications in musculoskeletal repair, metabolic engineering, and regenerative medicine. Recent studies include gamma-secretase inhibitors for obesity therapy and glycosaminoglycan-based scaffolds for muscle regeneration. Collaborations include work with MIT’s Robert Langer and University of Connecticut’s Cato Laurencin.

• Biomaterials
• Regenerative Engineering
• Drug Delivery
• +۴ مورد دیگر

Javier Saez Valero is a Professor in the Department of Biochemistry and Molecular Biology at Miguel Hernandez University of Elche, where he also serves as Deputy Vice Rector for Research - Management of Research and Transfer. His academic roles include teaching Biochemistry I in the Bachelor's in Medicine program and courses in the Master's in Neuroscience and Master's in Translational Neuropsychopharmacology, while coordinating the Doctorate in Neuroscience program. His research focuses on neurochemical mechanisms in neurodegenerative disorders, particularly Alzheimer's disease biomarker discovery in cerebrospinal fluid and blood. Key areas include NMDA receptor dynamics, ACE2 fragments, apolipoprotein E interactions, and reelin signaling pathways. His work bridges molecular biochemistry with clinical neurology to develop diagnostic tools and understand disease pathogenesis. Analysis of his 15 most recent publications (2023-2025) reveals a dominant focus on Alzheimer's disease biomarkers, especially CSF protein alterations (nicastrin, ADAM10, ACE2). Significant themes include synaptic vs extrasynaptic receptor distributions, COVID-19 neurological impacts, and nanocarrier drug delivery limitations. His work consistently targets translational applications for early diagnosis and therapeutic development. No scientific awards were documented in the provided information. Professor Saez Valero provides academic guidance through tutorials and course coordination across undergraduate, master's, and doctoral programs. As Doctorate in Neuroscience coordinator, he oversees research training while managing institutional research transfer activities through the Vice Rectorate. His teaching spans biochemistry, neuropathology, and molecular neuroscience with laboratory components. He operates from Laboratory 241 at the Institute of Neurosciences (Campus de San Juan), a joint research center with CSIC. His work integrates with the university's Vice Rectorate for Research and Transfer, facilitating technology transfer and collaborative neuroscience research within the university's research infrastructure.

• Neurochemistry
• Alzheimer's Disease
• Biomarker Research
• +۳ مورد دیگر

Dr. Yazhen Zhu is an Assistant Professor and Research Pathologist at the David Geffen School of Medicine , University of California, Los Angeles (UCLA). She is affiliated with the Crump Institute for Molecular Imaging and the Department of Molecular and Medical Pharmacology . In addition to her academic role, she co-directs the liquid biopsy laboratory at UCLA, where she leads translational research programs in cancer and prenatal diagnostics. Education: MD, Wuhan University (2005) PhD in Pathology, Fudan University (2010) Residency in Pathology, Guangdong Provincial Hospital of TCM (2012) Research Interests: Dr. Zhu’s research focuses on the development and clinical translation of liquid biopsy-based diagnostic platforms . Her work explores the potential of circulating rare cells and extracellular vesicles (EVs) for noninvasive cancer and prenatal diagnostics. She has pioneered the use of click chemistry and nanosubstrates to enrich tumor-derived EVs and circulating tumor cells (CTCs), enabling high-sensitivity detection of oncogenic mutations and gene expression profiles. Her translational programs involve close collaboration with clinicians across multiple departments at UCLA and Cedars-Sinai Medical Center. Scientific Contributions: Dr. Zhu has published extensively on novel diagnostic assays for hepatocellular carcinoma, prostate cancer, ovarian cancer, and placental disorders. Her work spans from single-cell profiling and spatial transcriptomics to CRISPR-based gene therapy , reflecting a broad and integrative approach to precision medicine. Research Collaborations & Labs: She co-directs the Liquid Biopsy Laboratory at UCLA, which serves as a hub for interdisciplinary research involving molecular imaging, pharmacology, and clinical pathology. The lab collaborates with departments such as Liver Transplant Surgery, Pancreatic Cancer Surgery, Thyroid Surgery, Medical Oncology, and Maternal-Fetal Medicine.

• Liquid Biopsy
• Cancer Diagnostics
• Extracellular Vesicles
• +۶ مورد دیگر

Carsten Hopf is a Professor of Bioanalytics and Drug Discovery at Mannheim University of Applied Sciences, leading the Institute of Instrumental Analytics and Bioanalytics and the CeMOS (Center for Mass Spectrometry and Optical Spectroscopy). His work focuses on developing spatially resolved omics technologies (e.g., MALDI-MS imaging) for neurodegenerative and oncological research. He explores lipidomics, proteomics, and metabolomics to understand Alzheimer's disease, glioblastoma, and other neurodegenerative disorders. Key projects include the SMART-CARE-2 BMBF initiative (2023–2026) and DFG-funded research on spatial multi-omics in glioblastoma (SFB 1389). Research interests center on mass spectrometry innovations, including matrix optimization, AI-driven data analysis, and multimodal imaging (e.g., infrared microscopy integration). His lab develops label-free cell assays for drug discovery and studies molecular mechanisms of neurodegeneration. Collaborations span academia and industry, with projects like the M 2 Aind partnership addressing 3D cell culture toxicity assessments. Grants include BMBF, DFG, and EU funding for systems medicine, organoid analysis, and mass spectrometry cores. His technological advancements aim to improve biomarker discovery and translational medicine in neuro-oncology and neurodegeneration.

• Bioanalytics
• Drug Discovery
• Mass Spectrometry Imaging
• +۶ مورد دیگر

Professor Nick Fox is a leading clinical academic in neurodegenerative diseases, currently serving as Professor of Clinical Neurology at the Queen Square Institute of Neurology, University College London . He is also Director of the Dementia Research Centre and an Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery. Key Affiliations: University College London Dementia Research Centre National Hospital for Neurology and Neurosurgery Research Focus: Fox is renowned for pioneering MRI-based methods to improve early detection, differential diagnosis, and progression monitoring of cognitive disorders, particularly familial dementias (Alzheimer's and frontotemporal lobar degenerations). His work integrates biomarkers, genetic analysis, and neuroimaging to assess disease-modifying therapies. Recent Publications highlight his contributions to amyloid-targeting therapies (e.g., gantenerumab, donanemab), plasma biomarker validation (p-tau181, β-synuclein), and genetic predictors of Alzheimer's onset. His studies often appear in high-impact journals like Nature , Brain , and Lancet Neurology . Scientific Awards & Appointments: Weston Brain Institute International Outstanding Achievement Award NIHR Senior Investigator Academia Europaea Member Royal College of Physicians Fellowship Teaching & Leadership: Fox contributes to UCL's MSc programs and international postgraduate courses, including the UCL-Gothenburg Biomarkers Course. He co-founded Rare Dementia Support , a network providing resources for patients with inherited cognitive disorders.

• Neurodegenerative Diseases
• Alzheimer's Disease
• Frontotemporal Dementia
• +۶ مورد دیگر

Dr. Yulia Nefedova is an Associate Professor in the Molecular and Cellular Oncogenesis Program at The Wistar Institute's Ellen and Ronald Caplan Cancer Center. She joined Wistar in 2013 as an assistant professor in the Tumor Microenvironment and Metastasis program, was promoted to associate professor in the Immunology, Microenvironment and Metastasis Program in 2017, and transitioned to her current position in the Molecular and Cellular Oncogenesis Program in 2024. Dr. Nefedova's research focuses on understanding molecular mechanisms by which the bone marrow microenvironment promotes tumor survival and progression, with particular emphasis on multiple myeloma. Her laboratory investigates how interactions between bone marrow neutrophils and multiple myeloma cells promote disease progression and chemoresistance, with specific interest in neutrophil extracellular traps (NETs) and the S100A9 protein. Analysis of her 15 most recent publications reveals a consistent focus on neutrophil biology within the tumor microenvironment, particularly their role in promoting cancer progression and therapy resistance. Her work spans immunology, cancer biology, and molecular oncology with increasing emphasis on therapeutic targeting of neutrophil-mediated processes. Dr. Nefedova's laboratory includes Research Assistant Melissa Haddadi and Lab Assistants Hsuan-Yu Lin and Hannah Lee. She maintains active collaborations with prominent researchers including Dr. Dmitry Gabrilovich, as evidenced by their frequent co-authorship.

• Cancer Immunology
• Tumor Microenvironment
• Multiple Myeloma
• +۵ مورد دیگر

Prof. Dr. Harald Steiner serves as a Group Leader at the German Center for Neurodegenerative Diseases (DZNE) in Munich, Germany, where he directs biochemical research on γ-secretase mechanisms central to Alzheimer's disease pathogenesis. His work focuses on molecular substrate recognition and activity modulation of this critical enzyme complex within the institution's neuroscience research framework. Dr. Steiner's research investigates the proteolytic processing of amyloid-β precursor protein (APP) by the γ-secretase complex—composed of presenilin, nicastrin, APH-1, and PEN-2—which generates amyloid-β peptides that accumulate in senile plaques. His laboratory examines intramembrane cleavage mechanisms to elucidate fundamental biochemical principles underlying Alzheimer's disease progression and identify potential therapeutic intervention points. The research group operates from DZNE's Munich site at Feodor-Lynen-Str. 17, employing biochemical and molecular approaches to dissect γ-secretase function. This work contributes to the broader institutional mission of advancing neurodegenerative disease understanding through basic science research, with implications for developing disease-modifying treatments targeting pathological proteolytic pathways.

• Alzheimer's Disease
• Amyloid-β
• γ-Secretase
• +۳ مورد دیگر

Kashif Mehmood is a Research Fellow in the Genetics Department at Yale School of Medicine, Yale University. His research focuses on virology, cell biology, and molecular mechanisms of viral entry and host-pathogen interactions. He investigates JC polyomavirus entry dynamics mediated by serotonin receptors, influenza hemagglutinin interactions with membrane lipids, and retromer-mediated transport pathways. Additionally, he explores microbial production of keratinase for sustainable waste management. His work bridges virology, neuroscience, and biotechnology, with implications for understanding viral pathogenesis and developing eco-friendly enzymatic solutions. Research interests include viral trafficking mechanisms, receptor-ligand interactions, lipid signaling, and industrial enzyme applications. Notable contributions address JC polyomavirus entry via serotonin receptors, influenza virus membrane fusion dynamics, and Bacillus velezensis-derived keratinase for keratin waste degradation.

• Virology
• Cell Biology
• Molecular Biology
• +۴ مورد دیگر

Margaret Hostetter is an Adjunct Professor at Yale University's School of Medicine, serving as Physician-in-Chief at Yale-New Haven Children's Hospital and Chair of the Department of Pediatrics since 2002. She leads the Yale Child Health Research Center and specializes in pediatric infectious diseases, particularly Candida albicans and Streptococcus pneumoniae. Her research focuses on fungal pathogenesis, biofilm formation, and mechanisms of host invasion. Hostetter holds five patents and has received prestigious awards including membership in the National Academy of Sciences' Institute of Medicine. Education: Fellowship: Boston Children's Hospital, Harvard (1980) Residency/Internship: Boston Children's Hospital, Harvard (1978) Research Interests: Hostetter’s work explores Candida albicans pathogenesis, including adhesion, biofilm inhibition (e.g., via statins), and interactions with the gastrointestinal tract. Her lab investigates mitochondrial proteome roles in fungal morphogenesis and E-cadherin cleavage mechanisms disrupting intestinal barriers. Grants & Activities: Program Director, NIH-funded Pediatric Scientist Development Program NIH Peer Review Member (2008–2011) Former Chair, Division of Pediatric Infectious Diseases, University of Minnesota Awards: E. Mead Johnson Award for Pediatric Research Institute of Medicine Membership (2001) NIH Blue Ribbon Panel Appointment (2003) Labs/Teams: Directs the Yale Child Health Research Center, focusing on translational pediatric research and mentoring physician-scientists.

• Pediatrics
• Infectious Diseases
• Medical Mycology
• +۳ مورد دیگر

Giuseppe Faraco is an Assistant Professor of Neuroscience at the Brain and Mind Research Institute, Weill Cornell Medical College. His research focuses on neurovascular dysfunction, cognitive impairment, and the interplay between hypertension, immune responses, and brain health. Education: Ph.D. and M.D. from University of Florence Faculty of Medicine and Surgery. Research interests center on neurovascular biology, dietary impacts on brain function, and immune-mediated cognitive decline. His work explores hypertension, tau phosphorylation, gut-brain axis, and blood-brain barrier dynamics in neurodegenerative diseases. Recent publications highlight mechanisms linking hypertension, inflammation, and cognitive dysfunction, with a focus on endothelial-immune crosstalk and dietary factors. Grants include funding from Cure Alzheimer’s Fund and National Institute of Neurological Disorders & Stroke to study hypertension, neurovascular dysregulation, and gut immunity.

• Neurovascular Biology
• Cognitive Neuroscience
• Hypertension Effects on Brain
• +۷ مورد دیگر

Robin Williams is a Professor of Molecular Cell Biology at the Department of Biological Sciences and Head of the Centre for Biomedical Sciences at Royal Holloway University of London. His research focuses on molecular cell biology, neuroscience, and pharmacology, using the social amoeba Dictyostelium as a model system to study epilepsy, Alzheimer’s, bipolar disorder, and drug development. He has pioneered 3Rs initiatives (Replace, Reduce, Refine) to reduce animal testing in research. Education: PhD in Molecular Cell Biology (University of Melbourne, 1994), postdoctoral training at St Andrews University and UCL. Joined Royal Holloway in 2006. Research Interests: Epilepsy treatments, Alzheimer’s disease mechanisms, bipolar disorder pharmacology, natural product therapeutics, bitter taste mechanisms, and translational drug discovery. His work emphasizes developing safer treatments and advancing non-animal research models. Key Collaborations: Prof Matthew Walker (epilepsy research), Prof Alan Kimmel (protein conservation studies), GlaxoSmithKline (bitter taste research). Industry partnerships include Vitaflo Ltd (ketogenic therapies). Recent Articles: Focus on medium-chain fatty acids’ roles in energy metabolism, cannabinoid mechanisms, and Dictyostelium-based drug discovery. Highlights include identifying the molecular basis of the ketogenic diet and novel treatments for drug-resistant epilepsy. Awards & Esteem: Member of Global Executive Board for the International Neurological Ketogenic Society, advisor to epilepsy charities, and organizer of international conferences. Recognized for contributions to 3Rs and translational research. Grants & Funding: Multiple BBSRC and MRC grants for epilepsy and metabolic research. Leads projects on safer epilepsy drugs and cannabinoid mechanisms. Labs/Teams: Active in the Centre for Biomedical Sciences, collaborating across disciplines to bridge basic science and clinical applications.

• Molecular Cell Biology
• Neuroscience
• Pharmacology
• +۸ مورد دیگر

Dr. Cesar L. Moreno is a Postdoctoral Research Associate and Dr. John and Anne Chong Genome Editing and Stem Cell Research Fellow at the School of Life and Environmental Sciences, The University of Sydney, with an adjunct appointment as Associate Lecturer at the Kirby Institute, University of New South Wales. His work focuses on developing functional genomic tools for disease modeling using stem cells and mouse models. Education: PhD in Neuroscience from Icahn School of Medicine at Mount Sinai (2015) Postdoctoral training at Gandy Lab and New York Stem Cell Foundation (2015-2017) Research at UQ-StemCARE Centre, University of Queensland (until 2020) Dr. Moreno's research centers on CRISPR-based genetic screens in stem cells to investigate diseases like COVID-19 and biological processes including neural development and ageing. He integrates functional genomic and epigenomic approaches to uncover molecular pathways in neurodegenerative disorders, metabolic diseases, and viral pathologies, with emphasis on translating findings into therapeutic strategies. His 15 most recent publications reveal a strong trajectory in genome editing technologies, stem cell disease modeling, and virology, particularly SARS-CoV-2 research. Key themes include CRISPR screening innovations, Alzheimer's disease mechanisms using iPSC models, metabolic regulation, and neuroinflammation, demonstrating consistent interdisciplinary collaboration. Scientific Awards: Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows F31 (2011-2015) Travel Scholarship for Aging and Diseases of Aging Keystone Symposium, Tokyo, Japan (2012) Dr. Moreno currently supervises two research students on dementia-related projects and secured a 2022 NHMRC Ideas Grant for the "UNIVERSAL NEUROPHOTONIC INTERFACE" project. He serves as a member of the Charles Perkins Centre and leads four major research initiatives spanning CRISPR barcoding, SARS-CoV-2 pathology, circadian rhythms in brain development, and neurophotonic stem cell models.

• Functional Genomics
• CRISPR Technology
• Stem Cell Research
• +۴ مورد دیگر